GNI Group Ltd.
Notice of Completion of Acquisition of Shares of ZOO LABO Inc. (Consolidation as a Subsidiary)
Acquired shares of ZOO LABO Inc. on December 29, 2025, making it a consolidated subsidiary. Acquisition funds were raised through an overseas public offering in July 2025.
Key Figures
- Share Acquisition Date: December 29, 2025
- ZOO LABO Revenue (Fiscal Year December 2024): 1,723 million yen
- Capital (ZOO LABO): 85,750,000 yen
AI要約
Overview of the M&A
GNI Group Co., Ltd. has acquired shares of ZOO LABO Inc., a company engaged in the manufacturing of dental prosthetics and dental technology business utilizing CAD/CAM, and has made it a consolidated subsidiary as of December 29, 2025. The acquisition funds were raised through an overseas public offering conducted in July 2025. ZOO LABO Inc. excels in providing high-quality dental prosthetics and promoting digitalization, aiming to create synergies with our MedTech business.
Outlook
The impact of this acquisition on the consolidated results for the fiscal year ending December 2025 will be minimal, with ZOO LABO Inc.'s performance reflected in consolidated results from the fiscal year ending December 2026 onwards. We believe this will contribute to mid- to long-term earnings improvement and plan to disclose additional information as necessary.
